Suppr超能文献

使用微量泵系统持续添加腺苷可改善温血全量心脏停搏液。

Continuous addition of adenosine with a micropump system improves warm whole blood cardioplegia.

作者信息

Agnihotri Arvind K, Recanati Maurice-Andre, White Jennifer K, Titus James, Fischer Jonathan I, Schon Jennifer, Torchiana David F

机构信息

Cardiac Surgical Unit, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Heart Surg Forum. 2003;6(4):264-72.

Abstract

BACKGROUND

Micropump additive systems allow for continuous modification of cardioplegia composition during heart surgery. Although the use of such systems in warm heart surgery is theoretically desirable, the role of the systems has been clinically limited by coronary vasoreactivity with higher potassium concentration and unreliable mechanical arrest at lower potassium concentration. Adenosine, a potent coronary vasodilator and arresting agent, has the potential to reduce the potassium concentration required for arrest and to improve distribution of cardioplegia. However, clinical use of adenosine has been limited by a short half-life in blood and difficulty in titrating the dose. This study tested the hypothesis that continuous addition of adenosine with an in-line linear micropump system would facilitate whole blood hyperkalemic perfusion for cardiac surgery.

METHODS

Canine hearts (n = 9) were randomized to 20 minutes of arrest with whole blood cardioplegia or cardioplegia with adenosine at either low (0.5 M) or high (8 M) concentration. Potassium was supplemented at an arresting dose (24 mEq/L) for 5 minutes and then at a maintenance dose (6 mEq/L) for an additional 15 minutes. Coronary flow was held constant (4 mL/kg per minute), and aortic root pressure was measured. Myocardial performance was assessed by measurement of the end-diastolic pressure to stroke volume relationship at constant afterload. Myocardial tissue perfusion was evaluated with colored microspheres.

RESULTS

During the initial period of high-concentration potassium arrest, coronary resistance rose progressively regardless of adenosine addition. Coronary resistance remained elevated during the period of low potassium perfusion, except when high-concentration adenosine was added. With addition of 8 M adenosine, coronary resistance returned to baseline, and left ventricular endocardial perfusion was augmented. Electromechanical quiescence improved with adenosine perfusion and was complete with high-dose adenosine addition. Function was preserved in all hearts.

CONCLUSION

Use of a modern micropump system allowed for continuous addition of adenosine and potassium to whole blood cardioplegia. Adenosine minimized potassium-induced coronary vasoconstriction and improved endocardial perfusion and mechanical quiescence. These findings supported addition of adenosine to the perfusate during warm whole blood cardioplegia.

摘要

背景

微泵添加剂系统可在心脏手术期间持续改变心脏停搏液的成分。尽管在温心手术中使用此类系统理论上是可取的,但该系统的作用在临床上受到限制,即较高钾浓度时冠状动脉血管反应性以及较低钾浓度时机械性停搏的不可靠性。腺苷是一种强效冠状动脉血管扩张剂和停搏剂,有可能降低停搏所需的钾浓度并改善心脏停搏液的分布。然而,腺苷的临床应用受到其在血液中半衰期短以及剂量滴定困难的限制。本研究检验了以下假设:使用在线线性微泵系统持续添加腺苷将有助于心脏手术中全血高钾灌注。

方法

将犬心脏(n = 9)随机分为两组,分别接受全血心脏停搏液停搏20分钟或添加低浓度(0.5 M)或高浓度(8 M)腺苷的心脏停搏液停搏20分钟。以停搏剂量(24 mEq/L)补充钾5分钟,然后以维持剂量(6 mEq/L)再补充15分钟。冠状动脉血流保持恒定(每分钟4 mL/kg),并测量主动脉根部压力。通过在恒定后负荷下测量舒张末期压力与每搏量的关系来评估心肌性能。用彩色微球评估心肌组织灌注。

结果

在高浓度钾停搏的初始阶段,无论是否添加腺苷,冠状动脉阻力均逐渐升高。在低钾灌注期间,冠状动脉阻力仍保持升高,除非添加高浓度腺苷。添加8 M腺苷后,冠状动脉阻力恢复至基线,左心室心内膜灌注增加。腺苷灌注可改善电机械静止,高剂量腺苷添加后完全静止。所有心脏的功能均得以保留。

结论

使用现代微泵系统可将腺苷和钾持续添加到全血心脏停搏液中。腺苷可将钾诱导的冠状动脉血管收缩降至最低,并改善心内膜灌注和机械静止。这些发现支持在温全血心脏停搏期间向灌注液中添加腺苷。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验